Viking Therapeutics (VKTX) Stock Chart & Stock Price History $27.61 -0.24 (-0.86%) As of 05/9/2025 03:58 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Viking Therapeutics Stock Price Performance 5 Day Performance-6.38%1 Month Performance+28.30%3 Month Performance-8.49%6 Month Performance-59.68%Year-To-Date Performance-31.39%1 Year Performance-62.51% Receive VKTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Viking Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address VKTX Stock Chart for Saturday, May, 10, 2025 VKTX Chart by TradingView Viking Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/09/2025$27.85$27.61-0.86%$28.73$27.451.73 million shs$3.10 billion05/08/2025$27.57$27.85+1.00%$28.65$26.373.59 million shs$3.13 billion05/07/2025$27.01$27.57+2.09%$27.66$26.903.39 million shs$3.10 billion05/06/2025$29.49$27.01-8.41%$29.08$26.734.01 million shs$3.03 billion05/05/2025$29.36$29.49+0.44%$29.73$28.703.15 million shs$3.31 billion05/02/2025$28.61$29.36+2.62%$30.28$29.094.44 million shs$3.30 billion05/01/2025$28.87$28.61-0.90%$29.01$27.693.45 million shs$3.21 billion04/30/2025$27.94$28.87+3.33%$29.02$27.065.24 million shs$3.24 billion04/29/2025$25.94$27.94+7.71%$29.68$26.5710.75 million shs$3.14 billion04/28/2025$24.99$25.94+3.80%$26.42$24.323.45 million shs$2.91 billion Get the Latest News and Ratings for VKTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Viking Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/25/2025$25.66$24.99-2.61%$25.40$24.363.95 million shs$2.81 billion04/24/2025$25.84$25.66-0.70%$26.85$24.873.53 million shs$2.88 billion04/23/2025$25.48$25.84+1.41%$26.95$25.704.21 million shs$2.90 billion04/22/2025$23.72$25.48+7.42%$25.54$24.003.54 million shs$2.86 billion04/21/2025$23.94$23.72-0.92%$24.68$23.302.72 million shs$2.66 billion04/18/2025$23.94$23.94$24.12$21.235.03 million shs$2.69 billion04/17/2025$23.60$23.94+1.44%$24.12$21.235.03 million shs$2.69 billion04/16/2025$23.11$23.60+2.12%$23.83$22.523.36 million shs$2.65 billion04/15/2025$24.57$23.11-5.94%$24.64$22.613.82 million shs$2.59 billion04/14/2025$22.22$24.57+10.58%$27.09$23.579.16 million shs$2.76 billion04/11/2025$21.52$22.22+3.25%$22.41$21.212.96 million shs$2.49 billion04/10/2025$23.10$21.52-6.84%$22.49$20.414.49 million shs$2.42 billion04/09/2025$19.98$23.10+15.62%$23.64$18.928.27 million shs$2.59 billion04/09/2025$19.98$23.10+15.62%$23.64$18.928.27 million shs$2.59 billion Related Companies Dr. Reddy's Laboratories Stock Chart Moderna Stock Chart Ascendis Pharma A/S Stock Chart Viatris Stock Chart Qiagen Stock Chart Roivant Sciences Stock Chart Revolution Medicines Stock Chart Lantheus Stock Chart BridgeBio Pharma Stock Chart Blueprint Medicines Stock Chart Receive VKTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Viking Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:VKTX) was last updated on 5/10/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredAll Signs Point To Collapse - 401(k)s/IRAs /Are DoomedRetiring? Not so Fast..Hold Onto Your Bootstraps For A Long Road AheadAmerican Hartford Gold | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredTrump’s Bitcoin Reserve is No Accident…Remember when they said crypto would never go mainstream? Well, something remarkable has happened… Blac...Crypto 101 Media | SponsoredTrump’s Secret WeaponWall Street is nervous. Billionaires are shifting assets. And everyday investors? Most are completely unprepa...American Alternative | Sponsored[FREE GIFT] New AI for retail tradersTradeAlgo has found a “backdoor way” for retail traders to profit from the AI arms race by developing its grou...TradeAlgo | SponsoredOne Stock Gold Blueprint to Survive the Market ChaosOne Stock Gold Blueprint to Survive the Market Chaos Markets are volatile, uncertainty is everywhere, and A...InvestorPlace | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viking Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Viking Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy vktx Stock Free vktx Stock Alerts